abstract |
The present specification generally relates to about 0.2 to about 35 weight percent of a therapeutic agent; And nanoparticles having from about 10 to about 99 weight percent of a biocompatible polymer, such as diblock poly (lactic) acid-poly (ethylene) glycol. Other aspects of the invention include methods of making such nanoparticles. |